Business Context and Reporting Period
Company: American Well Corporation (AMWL)
Filing Type: Form 8-K (Current Report)
Date of Report: September 2, 2021
Reporting Period: Specific event date of September 2, 2021
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document addresses corporate governance changes only.
Material Changes
The filing reports a reorganization of the Board of Directors to balance class sizes following several resignations:
- Dr. Peter Slavin: Resigned from his current class seat and was immediately appointed to fill a vacancy as a Class III director.
- Term: The new term ends in 2023.
- Committees and Compensation: Dr. Slavin continues to serve on the same committees, and there are no changes to his compensatory arrangements.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, risk factors, contingencies, or discussion of unusual items. It is strictly a notification of a director appointment.
Investor Verification Checklist
- Verify the total number of directors and the specific composition of each director class following this appointment.
- Review the Definitive Proxy Statement on Schedule 14A (filed April 30, 2021) for detailed biographical information on Dr. Slavin and other directors.
- Confirm if the "several resignations" mentioned as the catalyst for this change involved other key officers or directors not detailed in this specific 8-K.